Discover trends, market shifts, and competitive outlooks for the chronic cough industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Chronic Cough Market From 2025 To 2029?

The market for chronic cough has seen considerable growth over the past few years. The market is anticipated to rise from $8.22 billion in 2024 to $8.9 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The growth observed during the historical period can be associated with factors such as the high prevalence of underlying respiratory conditions, environmental contributors and air pollution, the usage of tobacco and smoking, respiratory infections, allergies and sensitivity to the environment.

Expectations are high for substantial expansion in the chronic cough market over the upcoming years. The market is set to escalate to a considerable $12.89 billion in 2029, with a compound annual growth rate (CAGR) of 9.7%. The projected growth within this time frame can be credited to the rise of therapies that target specific pathways, a heightened understanding of coughs related to reflux, global measures to quit smoking, and policies related to environmental and occupational health. Significant trends predicted for this same period involve improvements in diagnostic technologies, patient-oriented strategies, innovative treatments targeting neurogenic cough, telemedicine for managing chronic cough, and research centered on central sensitization.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Chronic Cough Market?

Accelerated market expansion for chronic cough is projected to be fueled by an increasing occurrence of cough. This common reflex, which is typically a reaction to irritation, mucus, or foreign substances, aids in clearing the passage of air by forcefully expelling air from our lungs. Coughs persisting for a minimum of eight weeks are classified as chronic. Hence, a surge in cough incidents also increases chronic cough cases. For example, the Florida Health, a health department based in the United States, reported in March 2022, that a total of 80 patients were identified in 2021, with incidents of 41.0 and 1.4 per 100,000 years, correspondingly. Moreover, in 2023, 28 cases of pertussis were documented across 13 countries. Correspondingly, the Statens Serum Institut, a Denmark-based disease surveillance department, stated in March 2022, that the number of pertussis cases had soared by 41% from November 2022 to April 2023, relative to November 2021–April 2022 in Denmark. Consequently, the escalating prevalence of cough is stimulating the growth of the chronic cough market.

Which Key Market Segments Comprise the Chronic Cough Market and Drive Its Revenue Growth?

The chronic cough market covered in this report is segmented –

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes

2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route Of Administrations

3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

2) By Corticosteroids: Inhaled Corticosteroids, Systemic Corticosteroids

3) By Decongestants: Oral Decongestants, Nasal Decongestants

4) By Combination Drug: Antihistamine And Decongestant Combinations, Cough Suppressant And Expectorant Combinations

5) By Antibiotics: Macrolides, Penicillins, Cephalosporins

6) By Acid Blockers: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists

7) By Other Drug Classes: Mucolytics, Cough Suppressants, Herbal Remedies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12109&type=smp

Which Areas Are Leading Regions in the Chronic Cough Market Expansion Across the Globe?

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theChronic Cough Market Direction?

Leading entities in the chronic cough market are focusing on producing novel items such as biosimilars in an effort to consolidate their market standing. These biosimilars, used in the treatment of diseases like cancer, autoimmune disorders, and diabetes, offer a more cost-efficient substitute to existing biologics. Consider, for example, in July 2024, Sandoz, a pharmaceutical firm based in Switzerland, introduced its biosimilar Pyzchiva (ustekinumab) throughout Europe, with a focus on chronic inflammatory conditions such as plaque psoriasis, psoriatic arthritis and Crohn’s disease. This biosimilar holds particular importance as it is Europe’s first-ever with all reference medicine strengths, including the initiation dosage for Crohn’s disease. Cultivated in collaboration with Samsung Bioepis, Sandoz is set on broadening access to effective treatments for millions impacted by these illnesses. This release showcases Sandoz’s dedication to delivering affordable healthcare solutions and advancing wellbeing for patients throughout Europe.

View the full report here:

https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

How Is the Chronic Cough Market Conceptually Defined?

Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model